Loading
Loading
Organ & Bioregulator Research · 20mg
Janoshik-tested · 10 vials per kit
Vilon is a synthetic dipeptide bioregulator studied in preclinical research for its broad tissue-regulatory and anti-aging properties. Research has examined its potential to boost skin collagen expression, support stem cell activation and proliferation, accelerate wound healing, regulate fibroblast activity, improve cardiovascular function, and modulate renal microvascular permeability. Studies have also explored adjuvant applications in liver disease, diabetes, and radiation injury models.
≥98%
Purity
Lyophilised
Format
2–3 wks
Arrival
Don't want to wait 3 weeks?
Check local stock — weekday same/next-day delivery available.
Chemical Properties
Need to work out your dose?
Use our reconstitution calculator — syringe units in seconds.
Research Use Only — Disclaimer
This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.
Vilon
Lys-Glu Dipeptide
Vilon is a synthetic dipeptide (lysylglutamic acid, Lys-Glu) and one of the Khavinson bioregulatory peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology. Classified as a thymus bioregulator, it is designed to convey regulatory signals that restore age-related functional decline in lymphoid tissue.
Khavinson short peptide bioregulators are proposed to act through direct binding to double-stranded DNA at promoter regions — altering chromatin organisation and histone modification patterns to influence gene transcription in target tissues. Vilon has been studied for effects on thymic lymphocyte populations, IL-2 production, and immune cell proliferation in aged animal models.
Russian bioregulator research describes normalisation of immune parameters in aged and immunocompromised animals, including improved T-cell and NK-cell activity. Vilon has been studied in combination with other bioregulatory peptides as part of organ-targeted protocols. The published literature is predominantly from Russian-language sources; independent Western replication is limited.
For research reference only. All information pertains to preclinical or published human trial data. Not intended as medical advice. This product is for research use only.
Don't have supplies? Grab them while you're here.
